Elicio Therapeutics (ELTX) Research & Development (2020 - 2026)
Elicio Therapeutics (ELTX) reported Research & Development of $6.81 million for Q2 2026, down 2.8% from $7.01 million a year earlier but up 0.8% from the prior quarter.
Powered by 
Analysis
Elicio Therapeutics (ELTX) Research & Development (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Elicio Therapeutics' Research & Development came in at $23.69 million, down 27.6% year-over-year; for FY2025, it was $24.9 million, down 26.0% from FY2024.
- Research & Development has a five-year compound annual growth rate of -8.6% (FY2020 to FY2025).
- By year, Research & Development came in at $33.66 million in FY2024 (+41.1%), $23.85 million in FY2023 (+31.7%), $18.1 million in FY2022 (-62.8%) and $48.7 million in FY2021 (+24.9%).
- Five-year quarterly Research & Development spans a low of $4.29 million in Q4 2022 and a high of $13.29 million in Q3 2021.
- Year over year, Research & Development has now declined in each of the last five quarters, with an average decline of 4.6% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q3 2021 (growth of 118.3%); the low point was Q3 2022 (a decline of 65.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.76 million (Q1 2026), $5.08 million (Q4 2025) and $5.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,131.80 Bn | 1,100.39 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 614.01 Bn | 532.53 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.59 Bn | 476.70 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.81 Bn | 261.80 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.50 Bn | 235.19 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.24 Bn | 191.64 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.15 Bn | 165.35 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.16 Bn | 116.81 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Elicio Therapeutics | 31.37 Mn | -46.25 Mn | - | 6.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.81 Mn |
| Mar 31, 2026 | 6.76 Mn |
| Dec 31, 2025 | 5.08 Mn |
| Sep 30, 2025 | 5.04 Mn |
| Jun 30, 2025 | 7.01 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Dec 31, 2024 | 10.71 Mn |
| Sep 30, 2024 | 7.21 Mn |
| Jun 30, 2024 | 8.18 Mn |
| Mar 31, 2024 | 7.56 Mn |
| Dec 31, 2023 | 6.16 Mn |
| Sep 30, 2023 | 7.26 Mn |
| Jun 30, 2023 | 4.94 Mn |
| Mar 31, 2023 | 5.48 Mn |
| Dec 31, 2022 | 4.29 Mn |
| Sep 30, 2022 | 4.59 Mn |
| Jun 30, 2022 | 5.04 Mn |
| Mar 31, 2022 | 11.67 Mn |
| Dec 31, 2021 | 6.67 Mn |
| Sep 30, 2021 | 13.29 Mn |
API Access
Elicio Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ELTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ELTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ELTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();